Investigation on the antiplatelet activity of pyrrolo[3,2-c]-pyridine-containing compounds

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 3, 2003, Pages 323-332

  Voskressensky, Leonid G ^b   de Candia, Modesto ^a   Carotti, Andrea ^a   Borisova, Tatiana N ^b   Kulikova, Larisa N ^b   Varlamov, Alexey V ^b   Altomare, Cosimo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDIN 2 YL)ETHANONE; 2 (2 CHLOROBENZYL) 8 METHOXY 2,3,4,5 TETRAHYDRO 1H PYRIDO[4,3 B]INDOLE OXALIC ACID; 2 BENZYLAMINOMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDINE; 2 ETHYL 2,3,4,5 TETRAHYDRO 1H PYRIDO[4,3 B]INDOLE; 2 [(4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDIN 2 YL)METHYLENE]MALONONITRILE; 2,2,2 TRIFLUORO 1 (4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDIN 2 YL)ETHANOL; 2,2,2 TRIFLUORO 1 (4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDIN 2 YL)ETHANONE; 2,3,4,5 TETRAHYDRO 1H PYRIDO[4,3 B]INDOLE DERIVATIVE; 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDINE DERIVATIVE; 4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDINE 2 CARBALDEHYDE OXIME; 4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDINE 2 CARBONITRILE; 5 ACETYL 1 VINYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDINE DERIVATIVE; 5 BENZYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDINE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; N BENZYL N [(4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDIN 2 YL)METHYL]AMINE MONOOXALIC ACID; N [(4,5,7 TRIMETHYL 4,5,6,7 TETRAHYDRO 1H PYRROLO[3,2 C]PYRIDIN 2 YL)METHYL]PROPANE 1,3 DIAMINE MONOOXALIC ACID; PYRROLO[3,2 C]PYRIDINE DERIVATIVE; THROMBOXANE A2; TICLOPIDINE; UNCLASSIFIED DRUG;

ADRENALIN RELEASE; ADULT; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EXPERIMENTATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIPOPHILICITY; NORMAL HUMAN; PARTITION COEFFICIENT; PHYSICOCHEMICAL MODEL; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA;

EID: 0347033231     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702676     Document Type: Article

References (32)

1. Aliev, A. E., Sinitsyna, A. A., Borisova, T. N., Stazharova, I. A., Prostakov, N. S., Varlamov, A. V. (1993) Carbon-13 and proton NMR study of the stereochemistry of N-unsubstituted and N-vinyl-4,5,7-trimethyl-4,5,6,7-tetrahydropyrrolo[3,2-c]pyridines and their nitro derivatives. Chem. Heterocycl. Compd. (Engl. Transl.) 29: 65-71
2. Altomare, C., Cellamare, S., Carotti, A., Ferappi, M. (1993) Linear solvation energy relationships in reversed-phase liquid chromatography. Examination of Deltabond C8 as stationary phase for measuring lipophilicity parameters. Quant. Struct.-Act. Relat. 12: 261-268
3. Altomare, C., Cellamare, S., Carotti, A., Ferappi, M. (1994) Linear solvation energy relationships in reversed-phase liquid chromatography. Examination of RP-8 stationary phases for measuring lipophilicity parameters. Farmaco 49: 394-401
4. Altomare, C., Summo, L., Cellamare, S., Varlamov, A. V., Voskressensky, L. G., Borisova, T. N., Carotti, A. (2000) Pyrrolo[3,2-c]pyridine derivatives as inhibitors of platelet aggregation. Bioorg. Med. Chem. Lett. 20: 581-584
5. Berger, P. B. (1999) The thienopyridines in coronary artery disease. Curr. Cardiol. Rep. 1: 192-198
6. Borisova, T. N., Varlamov, A. V., Sergeeva, N. D., Soldatenkov, A. T., Zvolinskii, O. V. (1987) Pyrrolo[3,2-c]piperidines. Chem. Heterocycl. Compd. (Engl. Transl.) 23: 799-803
7. Borisova, T. N., Stazharova, I. A., Aliev, A. E., Prostakov, N. S., Varlamov, A. V. (1991) Synthesis and nitration of NH- and N-vinyl-4,5,7-trimethyl-4,5,6,7-tetrahydropyrrolo[3,2-c]pyridines. Chem. Heterocycl. Compd. (Engl. Transl.) 27: 1105-1110
8. Born, G. V. R. (1962) Aggregation of blood platelets by adenosine diphosphate (ADP) and its reversal. Nature 194: 927-929
9. Calverley, D. C. (2001) Antiplatelet therapy in the elderly. Aspirin, ticlopidine-clopidogrel, and GPIIb/GPIIIa antagonists. Clin. Geriatr. Med. 17: 31-48
10. Cattanach, C. J., Cohen, A., Heath-Brown, B. J. (1968) Studies in the indole series. IV. Tetrahydro-1H-pyrido[4,3-b]-indoles as serotonin antagonists. J. Chem. Soc. [Perkin 1] 10: 1235-1243
11. Dogné, J.-M., De Leval, X., Benoit, P., Delarge, J., Masereel, B., David, J.-L. (2002) Recent advances in antiplatelet agents. Curr. Med. Chem. 9: 577-589
12. Feng, Z., Gollamudi, R., Dillingham, E. O., Bond, S. E., Lyman, B. A., Purcell, W. P., Hill, R. J., Korfmacher, W. A. (1992) Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines. J. Med. Chem. 35: 2952-2958
13. Gardell, S. J. (1993) The search for the ideal thrombolytic agent: Maximize the benefit and minimize the risk. Toxicol. Pathol. 21: 190-198
14. Ha-Duong, N.-T., Dijols, S., Macherey, A.-C., Goldstein, J. A., Dansette, P. M., Mansuy, D. (2001) Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry 40: 12112-12122
15. Hankey, G. J. (2001) Current oral antiplatelet agents to prevent atherothrombosis. Cerebrovasc. Dis. 11 (Suppl. 2): 11-17
16. Hays, W. L. (1981) Statistics. 3rd edn, CBS College Publishing, New York
17. Kunapuli, S. P. (1998) Multiple P2 receptor subtypes on platelets: A new interpretation of their function. Trends Pharmacol. Sci. 19: 391-394
18. Lova, P., Paganini, S., Sinigaglia, F., Balduini, C., Torti, M. (2002) A Gi-dependent pathway is required for activation of small GTPase Rap1B in human platelets. J. Biol. Chem. 277: 12009-12015
19. Menke, J. B. (1925) Nitrating with nitrates. Rec. Trav. Chim. Pays Bas 44: 141-149
20. Mewshaw, R. E., Abreu, M. E., Silverman, L. S., Mathew, R. M., Tiffany, C. W., Bailey, M. A., Karbon, E. W., Fenkany, J. W., Kaiser, C. (1993) Examination of the D2/5-HT2 affinity ratios of resolved 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: An enantioselective approach toward the design of potential atypical antipsychotics. J. Med. Chem. 36: 3073-3076
21. Quintana, R. P., Lasslo, A., Dugdale, M., Goodin, L. L. (1981) Relationships between the chemical constitution of carbamoylpiperidines and related compounds, and their inhibition of ADP-induced human blood platelet aggregation. Thromb. Res. 22 (Suppl.): 665-680
22. 12 receptor as a therapeutic target in cardiovascular disease. Platelets 12: 197-209
23. Tanaka, A., Nakamura, K., Nakanishi, I., Fujiwara, H. (1994) A novel and useful descriptor for hydrophobicity, partition coefficient micellar-water, and its application to a QSAR study of antiplatelet agents. J. Med. Chem. 37: 4563-4566
24. Tanaka, A., Fujiwara, H. (1996) Quantitative structure-activity relationship study of fibrinogen inhibitors, [[4-(4-amidinophenoxy)butanoyl]aspartyl]valine (FK633) derivatives, using a novel hydrophobic descriptor. J. Med. Chem. 39: 5017-5020
25. Trofimov, B. A., Mikhaleva, A. I. (1994) Further development of the ketoxime-based pyrrole synthesis. Heterocycles 37: 1193-1232
26. Van De Graaff, E., Steinhubl, S. R. (2000) Antiplatelet medications and their indications in preventing and treating coronary thrombosis. Ann. Med. 32: 561-571
27. Varlamov, A. V., Borisova, T. N., Aliev, A. E., Stazharova, I. A., Sinitsyna, A. A., Sakhnova, E. A. (1993) Chemical transformations of 4,5,6,7-tetrahydro-4,5,7-trimethylpyrrolo[3,2-c]pyridine and its 2-formyl derivative. Chem. Heterocycl. Compd. (Engl. Transl.) 29: 582-588
28. Varlamov, A. V., Voskressensky, L. G., Borisova, T. N., Levov, A. N., Chernyhev, A. I. (1999) Heterocyclization of tropinone oximes and 3-methyl-3-azabicyclo[3.3.1]nonan-9-one with acetylene in a superbasic medium. Chem. Heterocycl. Compd. (Engl. Translation) 35: 613-616
29. Varlamov, A. V., Borisova, T. N., Voskressensky, L. G. (2002) Hydrogenated pyrrolo-pyridines. Synthesis and reactivity. Synthesis 2: 155-168
30. Weiss, H. J. (1983) Antiplatelet drugs: Pharmacological aspects. In: Liss, A. R. (ed.) Platelets: Pathophysiology and Antiplatelet Drug Therapy. Alan R. Liss Inc., New York, p. 46
31. Weksler, B. B. (2000) Antiplatelet agents in stroke prevention. Combination therapy: Present and future. Cerebrovasc. Dis. 10 (Suppl. 5): 41-48
32. Winer, B. J., Brown, D. R., Michels, K. M. (1991) Statistical Principles in Experimental Design. 3rd edn, McGraw-Hill, New York